Australia markets open in 5 hours 12 minutes

Clearmind Medicine Inc. (CMND)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1870+0.0170 (+1.45%)
As of 01:05PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.85M
Enterprise value -5.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.76
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.33

Trading information

Stock price history

Beta (5Y monthly) -1.69
52-week change 3-93.55%
S&P500 52-week change 323.57%
52-week high 323.7000
52-week low 30.9210
50-day moving average 31.3144
200-day moving average 34.7563

Share statistics

Avg vol (3-month) 3507.86k
Avg vol (10-day) 345.07k
Shares outstanding 53.26M
Implied shares outstanding 63.26M
Float 83.21M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (15 Apr 2024) 4160.15k
Short ratio (15 Apr 2024) 40.46
Short % of float (15 Apr 2024) 44.92%
Short % of shares outstanding (15 Apr 2024) 44.91%
Shares short (prior month 15 Mar 2024) 492.7k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 328 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Oct 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-49.59%
Return on equity (ttm)-181.83%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -5.83M
Net income avi to common (ttm)-8.09M
Diluted EPS (ttm)-6.8900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.37M
Total cash per share (mrq)2.87
Total debt (mrq)94.21k
Total debt/equity (mrq)1.87%
Current ratio (mrq)1.96
Book value per share (mrq)1.59

Cash flow statement

Operating cash flow (ttm)-4.66M
Levered free cash flow (ttm)1.27M